Cargando…

Network Pharmacology Reveals That Resveratrol Can Alleviate COVID-19-Related Hyperinflammation

Hyperinflammation is related to the development of COVID-19. Resveratrol is considered an anti-inflammatory and antiviral agent. Herein, we used a network pharmacological approach and bioinformatic gene analysis to explore the pharmacological mechanism of Resveratrol in COVID-19 therapy. Potential t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zijian, Ye, Qing, Duan, Xiaomei, Xiang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463930/ https://www.ncbi.nlm.nih.gov/pubmed/34580601 http://dx.doi.org/10.1155/2021/4129993

Ejemplares similares

In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis
por: Ge, Chenliang, et al.
Publicado: (2020)

Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)

Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection
por: Ezeonwumelu, Ifeanyi Jude, et al.
Publicado: (2022)

Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19
por: Zhao, Qiuchen, et al.
Publicado: (2022)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
por: Zheng, Chang-Qing, et al.
Publicado: (2021)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

Hyperinflammation with COVID-19: The key to patient deterioration?()()
por: Haigh, Kathryn, et al.
Publicado: (2020)

Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
por: Taha, Sara Ibrahim, et al.
Publicado: (2022)

Systematic Pharmacology Reveals the Antioxidative Stress and Anti-Inflammatory Mechanisms of Resveratrol Intervention in Myocardial Ischemia-Reperfusion Injury
por: Xing, Zuzhong, et al.
Publicado: (2021)

Exploring the Mechanism of Resveratrol in Reducing the Soft Tissue Damage of Osteoarthritis Based on Network Pharmacology and Experimental Pharmacology
por: Long, Zhiyong, et al.
Publicado: (2021)

Mechanistic analysis of resveratrol in cardiac hypertrophy by network pharmacology and animal experiments
por: Ren, Shan, et al.
Publicado: (2022)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
Publicado: (2020)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
por: -, -
Publicado: (2020)

Post VV-ECMO Weaning Hyperinflammation—Can Prophylactic Hemoadsorption Treatment Prevent Complications?
por: Kovacevic, Pedja, et al.
Publicado: (2023)

Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
por: Tanner, Tamara, et al.
Publicado: (2020)

IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)

Attenuating hyperinflammation in COVID-19: A change in paradigm?
por: Molnar, Zsolt, et al.
Publicado: (2020)

ACEi reduces hypertension-induced hyperinflammation in COVID-19
por: Lim, Gregory B.
Publicado: (2021)

Current Concepts of Hyperinflammation in Chronic Granulomatous Disease
por: Rieber, Nikolaus, et al.
Publicado: (2012)

The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
por: Chen, Jiezhong, et al.
Publicado: (2020)

Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022)

Fostering experimental and computational synergy to modulate hyperinflammation
por: Potapov, Ilya, et al.
Publicado: (2022)

In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation
por: Li, Xiaoyu, et al.
Publicado: (2023)

Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
por: McBride, Angela, et al.
Publicado: (2021)

COVID‐19: lambda interferon against viral load and hyperinflammation
por: Andreakos, Evangelos, et al.
Publicado: (2020)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19
por: Sohrabi, Yahya, et al.
Publicado: (2021)

The role of ibrutinib in COVID-19 hyperinflammation: A case report
por: Maynard, Suzanne, et al.
Publicado: (2021)

Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist
por: Papadopoulou, Charalampia, et al.
Publicado: (2020)

Resveratrol: Multi-Targets Mechanism on Neurodegenerative Diseases Based on Network Pharmacology
por: Wang, Wenjun, et al.
Publicado: (2020)

Mechanisms of resveratrol against diabetic wound by network pharmacology and experimental validation
por: Youjun, Ding, et al.
Publicado: (2023)

Exploring the mechanism of anti-fatigue of resveratrol based on network pharmacology and molecular docking, and in vitro studies
por: Ma, Peipei, et al.
Publicado: (2023)

The Nutritional Intervention of Resveratrol Can Effectively Alleviate the Intestinal Inflammation Associated With Celiac Disease Induced by Wheat Gluten
por: Yu, Tian, et al.
Publicado: (2022)

Hyperinflammation bei SARS-CoV-2-Infektion
Publicado: (2020)

Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK
por: Yang, Yan-jing, et al.
Publicado: (2016)

Resveratrol alleviates hypoxia/reoxygenation injury-induced mitochondrial oxidative stress in cardiomyocytes
por: Li, Tao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nequpgordgp1i80q6396ah3iql